Insider · CIK 0001679966
Grady Grant III
Files at APVO (Aptevo Therapeutics Inc.). First filing Nov 12, 2025, latest Nov 12, 2025.
In brief
Grady Grant III files SEC Form 4 as director at APVO (Aptevo Therapeutics Inc.). Since Nov 12, 2025, Grady Grant III has reported 1 open-market buy worth $20k and 0 open-market sells worth $0, the latest filed on Nov 12, 2025.
A track record needs three past buys with six months of prices behind them; Grady Grant III has 0, so none is measured yet.
The newest scored trade: bought $20k of APVO on Nov 10, 2025, filed Nov 12, 2025, scored 25 (weak). In the last 12 months: 1 buy worth $20k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
APVO: Aptevo Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | APVObuy Aptevo Therapeutics Inc. | $20k 13,513 shares | first purchase | - |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +400 | - | - | 1,150 | Aug 10, 2026 |
| Aug 6, 2026 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -400 | $0.00 | $0 | 0 | Aug 10, 2026 |
| Nov 10, 2025 | APVO Aptevo Therapeutics Inc. | POpen-market purchase Common Stock | +13,513 | $1.49 | $20k | 13,514 | Nov 12, 2025 |
| Aug 6, 2025 | APVO Aptevo Therapeutics Inc. | AGrant or award Restricted Stock Unitderivative | +7,200 | $0.00 | $0 | 7,200 | Aug 8, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Common Stock | +1 | - | - | 1 | Jul 21, 2025 |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | MOption exercise Restricted Stock Unitderivative | -1 | $0.00 | $0 | 0 | Jul 21, 2025 |
Questions about Grady Grant III
Answered from the filings on this page, as of the latest one.
Is Grady Grant III buying or selling?
In the last 12 months Grady Grant III reported 1 open-market buy worth $20k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $20k of APVO on Nov 10, 2025. Grants, option exercises and tax withholding are not counted.
How did Grady Grant III's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Grady Grant III has 0.
Where does Grady Grant III file Form 4?
Grady Grant III has filed Form 4 at APVO (Aptevo Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.